β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D
about
Airway hyperresponsiveness; smooth muscle as the principal actorStereoselective activity of 2-(4-amino-3-chloro-5- trifluomethyl-phenyl)-2-tert-butylamino-ethanol hydrochloride to improve the pulmonary function in asthma.Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells.Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease.Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonistsConstitutively active signaling by the G protein βγ-subunit mediates intrinsically increased phosphodiesterase-4 activity in human asthmatic airway smooth muscle cells.Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe AsthmaExtraction and elemental analysis of Coleus forskohlii extractG Protein βγ-subunit signaling mediates airway hyperresponsiveness and inflammation in allergic asthma.cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle.Aberrant DNA Methylation of Phosphodiesterase [corrected] 4D Alters Airway Smooth Muscle Cell Phenotypes.Inhibition of PI3K promotes dilation of human small airways in a rho kinase-dependent manner.Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cellsEpigenetic alterations by DNA methylation in house dust mite-induced airway hyperresponsiveness.Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.Active components of ginger potentiate β-agonist-induced relaxation of airway smooth muscle by modulating cytoskeletal regulatory proteins.Novel cAMP signalling paradigms: therapeutic implications for airway diseaseTargeting airway smooth muscle in airways diseases: an old concept with new twistsGenetic basis for personalized medicine in asthma.Untangling asthma phenotypes and endotypes.cAMP regulation of airway smooth muscle function.PDE inhibitors currently in early clinical trials for the treatment of asthma.TLR2 activation causes tachyphylaxis to β2 -agonists in vitro and ex vivo: modelling bacterial exacerbation.RGS5 gene and therapeutic response to short acting bronchodilators in paediatric asthma patients.Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout MiceNovel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility.TGF-β1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3.Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.Effect of Roflumilast on Airway Blood Flow in COPD: A Pilot Study.Epac Function and cAMP Scaffolds in the Heart and Lung.Compartmentalized cAMP responses to prostaglandin EP2 receptor activation in human airway smooth muscle cells.A pathophysiological role of PDE3 in allergic airway inflammation.PDK1/Akt/PDE4D axis identified as a target for asthma remedy synergistic with β2 AR agonists by a natural agent arctigenin.
P2860
Q28079233-CE4AFBFF-8E14-4740-A7EE-1448AEA4A9A8Q33733512-2D5CA107-C6D6-426F-84E1-99D6F39F50E2Q33799618-C51AEB2B-720B-406A-81E2-CCA09BF5CACEQ34621208-1D6C95B8-940D-4C4B-B7F2-B490DC7E2C1AQ34827999-857F5920-F2FD-4762-8F1A-6EFD7301A398Q35572333-A55858BD-1C4B-40AB-A0C6-494DE4DBAFABQ35645970-4DD5925C-1B68-4930-BDA9-424D94217E5CQ35679398-EF245A47-E37C-463E-A410-CC6BF207E9A7Q35772192-A32421D2-9CE4-4176-B455-DEB3DC574896Q36021241-35B8FEF4-3114-423F-BA70-3018BA839815Q36765933-8D3F64BB-B5F3-46C3-B206-FC0059141460Q37198370-12DC0B0F-F2A8-4015-8248-30FF1075656AQ37289808-5B84E85A-3EE5-4DDD-A396-3B97EB3FE465Q37297908-6AE7D119-40F5-4122-8E6B-F4DFA8685548Q37320983-9423BAF6-D228-4235-9905-DDCBFC6374E3Q37596098-5CC6B714-AE4E-48A5-B13C-87BDA6440CF9Q37947662-D9CE9F7F-474E-430F-B8DE-05DF49362E8CQ37955927-24CA0F97-19FE-4518-BA84-B09F7095233BQ37997823-2673C0D5-CFC0-4126-83D7-5C2E78708CF0Q38010795-9BCBC071-2557-4D9F-ADE3-1AB00A62C263Q38013462-D5F37443-CF39-4D79-9ACF-E5DB37985CE7Q38215280-A2E62EC2-38BD-4EDC-A1FF-7B5B5A7790EDQ39186404-625975D2-617C-418C-8C6A-6D9A7D46C002Q39237406-DD1897D8-30B8-46C5-8E79-D94548528BD6Q41681579-37E215EF-3C6E-4073-B452-50F99852FA66Q42368264-BD029615-73B5-4E8F-9CE4-EE0EE0F0A332Q42419157-72BE7456-DEDA-4D12-A206-E8F689F1ED33Q42516414-5269369A-9D6B-42C5-9CFE-3AF49ED8D6EDQ46038615-4908873A-A604-4297-A150-CC0632923833Q47642874-51410F1C-D4F6-43CA-B3B0-358692DBBA34Q48104933-BEE09E72-CE8E-4F64-A620-C5255BF517C4Q48295045-A6EAE58B-77E9-4CBA-82F7-ABE31BC20582Q49030605-E59A872C-09C4-4371-B943-F7F0B98281B4Q53790235-E8421BB3-2A94-485F-BC51-9CFBBFF7EBA4
P2860
β2-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@ast
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@en
type
label
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@ast
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@en
prefLabel
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@ast
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@en
P2093
P2860
P1433
P1476
β2-Agonist induced cAMP is dec ...... muscle due to increased PDE4D
@en
P2093
Janette K Burgess
Judith L Black
Kyoko Niimi
Lyn M Moir
Stephen B Liggett
Thomas Trian
P2860
P304
P356
10.1371/JOURNAL.PONE.0020000
P407
P577
2011-05-17T00:00:00Z